Category: 4. Acute Coronary Syndromes: Therapy Background: Thrombus aspiration (TA) before stenting of the infarcted related artery has beneficial impact on myocardial reperfusion and clinical outcome in randomised controlled trials. This study evaluated the effect of thrombus aspiration in a real world STEMI population.
1 hour post PCI ECG (core-lab analysis). Secondary endpoints were post PCI TIMI flow, infarct size and 30 day mortality.
Results: Between 1 January 2006 and 31 December 2009 3216 pts presented with STEMI of which TA-and ECG data were available in 2457 pts (76%). No differences in baseline characteristics were present between the years, except for a significant increase in the use of TA and pre-hospitally administered 2b/3a blockers. The use of TA increased from 2% in 2006 to 43% in 2009 (p<0.001). Final TIMI 3 flow, ST res, infarct size and 30 day mortality did not improve over the years. Multivariate analysis showed that age (OR 1.01, 95%CI 1.00-1.01), infarct location (OR 2.6, 95% CI 2.2-3.1), higher Killip class (OR 1.9, 95% CI 1.3-2.8) and the use of TA (OR 1.3, 95% CI 1.1-1.6), were independent predictors of high ST res (>3mm), whereas pre-hospital use of 2b/3a blockers (OR 0.7, 95% CI 0.6-0.9) was independently associated with low ST res (<3mm).
Conclusions:
This study shows that the use of TA increased over time but was not associated with improved outcome in daily practice in a high volume STEMI center. 
